insights from industryJeff HawkinsCEOQuantum-SiIn this interview, NewsMedical speaks with Jeff Hawkins, CEO of Quantum-Si, about the challenges of conventional proteomic methods, as well as how ...
MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...
News-Medical.Net on MSN
Highly sensitive CRISPR-based method designed to detect low-frequency cancer mutations
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
This eBook explores next-generation sequencing (NGS) methods and their applications in neurological and cancer research, with key content from BioTechniques’ digital hub and Taylor & Francis journals, ...
There is a revolution taking place in the field of genomics. Next-generation sequencing (NGS) is getting faster and less expensive with better computational tools, enabling researchers to sequence ...
In the largest study of its kind, the diagnostic yield of mNGS was greater than conventional test methods mNGS alone identified 34% more pathogens than all direct-detection methods combined 72% of ...
The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...
Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move ...
Whether you’re interested in why a living system works as it does or the reasons it goes awry, proteins are a critical part of the molecular picture. The proteins circulating in a person’s plasma can ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback